CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...